Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$121.18
-1.36-1.11%
At close: -
$121.18
0.000.00%
After Hours: 4:05 PM EDT
Comments
Loading...
Repligen Analyst Ratings and Price Targets | NASDAQ:RGEN | Benzinga
Repligen Corp has a consensus price target of $183.29 based on the ratings of 17 analysts. The high is $220 issued by Keybanc on February 15, 2024. The low is $150 issued by Canaccord Genuity on April 16, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., RBC Capital, and JP Morgan on May 5, 2025, April 30, 2025, and April 29, 2025, respectively. With an average price target of $186.33 between HC Wainwright & Co., RBC Capital, and JP Morgan, there's an implied 53.77% upside for Repligen Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
RBC Capital
JP Morgan
Canaccord Genuity
Evercore ISI Group
1calculated from analyst ratings
Analyst Ratings for Repligen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/05/2025 | Buy Now | 48.54% | HC Wainwright & Co. | Raghuram Selvaraju55% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2025 | Buy Now | 55.97% | RBC Capital | Conor McNamara36% | $202 → $189 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | 56.79% | JP Morgan | Rachel Vatnsdal64% | $200 → $190 | Maintains | Overweight | Get Alert |
| 04/16/2025 | Buy Now | 23.78% | Canaccord Genuity | Kyle Mikson36% | $170 → $150 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | 27.91% | Evercore ISI Group | Daniel Markowitz10% | → $155 | Initiates | → In-Line | Get Alert |
| 02/21/2025 | Buy Now | 69.17% | RBC Capital | Conor McNamara36% | $203 → $205 | Maintains | Outperform | Get Alert |
| 02/21/2025 | Buy Now | 65.04% | JP Morgan | Rachel Vatnsdal64% | $190 → $200 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 48.54% | HC Wainwright & Co. | Raghuram Selvaraju55% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 40.29% | Canaccord Genuity | Kyle Mikson36% | $165 → $170 | Maintains | Hold | Get Alert |
| 01/23/2025 | Buy Now | 48.54% | HC Wainwright & Co. | Raghuram Selvaraju55% | $240 → $180 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 36.16% | Canaccord Genuity | Kyle Mikson36% | → $165 | Initiates | → Hold | Get Alert |
| 11/14/2024 | Buy Now | — | Wolfe Research | Doug Schenkel71% | — | Initiates | → Peer Perform | Get Alert |
| 09/26/2024 | Buy Now | 69.17% | RBC Capital | Conor McNamara36% | $205 → $205 | Reiterates | Outperform → Outperform | Get Alert |
| 08/27/2024 | Buy Now | 48.54% | Wells Fargo | Brandon Couillard23% | → $180 | Initiates | → Overweight | Get Alert |
| 08/05/2024 | Buy Now | — | Benchmark | Robert Wasserman48% | — | Reiterates | → Hold | Get Alert |
| 07/31/2024 | Buy Now | 65.04% | JP Morgan | Rachel Vatnsdal64% | $190 → $200 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | 52.67% | UBS | Elizabeth Garcia70% | $205 → $185 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 56.79% | RBC Capital | Conor McNamara36% | $190 → $190 | Reiterates | Outperform → Outperform | Get Alert |
| 07/30/2024 | Buy Now | 40.29% | Stephens & Co. | Jacob Johnson62% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | Buy Now | 27.91% | Deutsche Bank | Justin Bowers47% | $180 → $155 | Upgrade | Hold → Buy | Get Alert |
| 06/18/2024 | Buy Now | — | Guggenheim | Subbu Nambi41% | — | Initiates | → Neutral | Get Alert |
| 05/02/2024 | Buy Now | 65.04% | JP Morgan | Rachel Vatnsdal64% | $230 → $200 | Maintains | Overweight | Get Alert |
| 02/22/2024 | Buy Now | 70.82% | Stifel | Daniel Arias78% | $165 → $207 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 81.55% | Keybanc | Paul Knight55% | $210 → $220 | Maintains | Overweight | Get Alert |
| 12/20/2023 | Buy Now | 73.3% | JP Morgan | Rachel Vatnsdal64% | $170 → $210 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | — | Benchmark | Robert Wasserman48% | — | Downgrade | Buy → Hold | Get Alert |
| 11/02/2023 | Buy Now | 40.29% | UBS | Elizabeth Garcia70% | $210 → $170 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 36.16% | Stifel | Daniel Arias78% | $200 → $165 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 65.04% | RBC Capital | Conor McNamara36% | $207 → $200 | Maintains | Outperform | Get Alert |
| 11/01/2023 | Buy Now | 73.3% | Keybanc | Paul Knight55% | $240 → $210 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | 48.54% | JP Morgan | Rachel Vatnsdal64% | $200 → $180 | Maintains | Overweight | Get Alert |
| 09/08/2023 | Buy Now | 57.62% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | 57.62% | RBC Capital | Conor McNamara36% | → $191 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | Buy Now | 65.04% | Craig-Hallum | Matt Hewitt57% | $207 → $200 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 60.92% | RBC Capital | Conor McNamara36% | $157 → $195 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 65.04% | Stephens & Co. | Jacob Johnson62% | $180 → $200 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | 52.67% | Wells Fargo | Timothy Daley54% | → $185 | Initiates | → Overweight | Get Alert |
| 07/06/2023 | Buy Now | 28.73% | RBC Capital | Conor McNamara36% | → $156 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/03/2023 | Buy Now | 29.56% | RBC Capital | Conor McNamara36% | $170 → $157 | Maintains | Sector Perform | Get Alert |
| 05/03/2023 | Buy Now | 73.3% | Stifel | Daniel Arias78% | $225 → $210 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 65.04% | Stephens & Co. | Jacob Johnson62% | $220 → $200 | Maintains | Overweight | Get Alert |
| 03/28/2023 | Buy Now | 89.8% | Benchmark | Robert Wasserman48% | → $230 | Initiates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | 98.05% | Keybanc | Paul Knight55% | $260 → $240 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 65.04% | SVB Leerink | Puneet Souda57% | $230 → $200 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 48.54% | Deutsche Bank | Justin Bowers47% | → $180 | Initiates | → Hold | Get Alert |
| 12/07/2022 | Buy Now | 56.79% | RBC Capital | Conor McNamara36% | → $190 | Initiates | → Sector Perform | Get Alert |
| 08/03/2022 | Buy Now | 126.94% | Stephens & Co. | Jacob Johnson62% | $220 → $275 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 106.3% | SVB Leerink | Puneet Souda57% | $220 → $250 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 114.56% | Keybanc | Paul Knight55% | $245 → $260 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | 75.77% | UBS | Elizabeth Garcia70% | → $213 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Repligen (RGEN) stock?
The latest price target for Repligen (NASDAQ:RGEN) was reported by HC Wainwright & Co. on May 5, 2025. The analyst firm set a price target for $180.00 expecting RGEN to rise to within 12 months (a possible 48.54% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Repligen (RGEN)?
The latest analyst rating for Repligen (NASDAQ:RGEN) was provided by HC Wainwright & Co., and Repligen reiterated their buy rating.
When was the last upgrade for Repligen (RGEN)?
The last upgrade for Repligen Corp happened on June 26, 2024 when Deutsche Bank raised their price target to $155. Deutsche Bank previously had a hold for Repligen Corp.
When was the last downgrade for Repligen (RGEN)?
The last downgrade for Repligen Corp happened on December 4, 2023 when Benchmark changed their price target from N/A to N/A for Repligen Corp.
When is the next analyst rating going to be posted or updated for Repligen (RGEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repligen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repligen was filed on May 5, 2025 so you should expect the next rating to be made available sometime around May 5, 2026.
Is the Analyst Rating Repligen (RGEN) correct?
While ratings are subjective and will change, the latest Repligen (RGEN) rating was a reiterated with a price target of $180.00 to $180.00. The current price Repligen (RGEN) is trading at is $121.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
